{
    "id": 915,
    "fullName": "FBXW7 del",
    "impact": "deletion",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "FBXW7 del indicates a deletion of the FBXW7 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 55294,
        "geneSymbol": "FBXW7",
        "terms": [
            "FBXW7",
            "AGO",
            "CDC4",
            "FBW6",
            "FBW7",
            "FBX30",
            "FBXO30",
            "FBXW6",
            "hAgo",
            "hCdc4",
            "SEL-10",
            "SEL10"
        ]
    },
    "variant": "del",
    "createDate": "07/10/2014",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 719,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, homozygous deletion of FBXW7 is conferred resistance to gamma secretase inhibitor, MRK-003, by activation of the NOTCH pathway and stablization of MYC as demonstrated in T cell acute lymphoblastic leukemia (T-ALL) cell lines (PMID: 17646409).",
            "molecularProfile": {
                "id": 1039,
                "profileName": "FBXW7 del"
            },
            "therapy": {
                "id": 1084,
                "therapyName": "MRK-003",
                "synonyms": null
            },
            "indication": {
                "id": 5602,
                "name": "T-cell adult acute lymphocytic leukemia",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 379,
                    "pubMedId": 17646409,
                    "title": "FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17646409"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16064,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, a patient with metastatic small-cell neuroendocrine prostate cancer with Aurka and Mycn protein overexpression, deletions of FBXW7, FANCA, and SMARCB1, and loss of PTEN and CDKN2A, responded to Alisertib (MLN8237) therapy with complete resolution of metastasis in 12 weeks and a 14-month complete radiological response prior to discontinuation of therapy due to illness (PMID: 30232224; NCT30232224).",
            "molecularProfile": {
                "id": 31395,
                "profileName": "AURKA over exp FBXW7 del MYCN over exp"
            },
            "therapy": {
                "id": 626,
                "therapyName": "Alisertib",
                "synonyms": null
            },
            "indication": {
                "id": 2992,
                "name": "prostate neuroendocrine neoplasm",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14171,
                    "pubMedId": 30232224,
                    "title": "A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30232224"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1039,
            "profileName": "FBXW7 del",
            "profileTreatmentApproaches": [
                {
                    "id": 4075,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "FBXW7 del"
                }
            ]
        },
        {
            "id": 31395,
            "profileName": "AURKA over exp FBXW7 del MYCN over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}